Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 256 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AccuGenomics Inc. | Activity: Production and Manufacturing | Company Description AccuGenomics manufactures custom gene expression tests to diagnose and monitor cancer treatment. Its technologies include Standard Nucleic Acid Quantification for RNA and DNA Sequencing for any NGS platform analysis. | Location Wilmington |
| |
Company Advanced Cell & Gene Therapy LLC | Activity: Support and Related | Company Description Advanced Cell & Gene Therapy is a consulting firm specializing in development and commercialization of cell therapy, gene therapy, immunotherapy, and regenerative medicine products. Expertise includes manufacturing (CMC), regulatory affairs, QA and strategy. | Location Chapel Hill |
| |
Company Almac Diagnostics LLC | Activity: Contract Research and Testing | Company Description Almac offers services for biomarker discovery, assay development/validation/testing and companion diagnostic co-development. Testing platforms include NGS, Microarray, qPCR and IHC. Regulatory and bioinformatics services are also available. | Location Durham |
| |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham |
| |
Company ArrayXpress Inc. | Activity: Contract Research and Testing | Company Description ArrayXpress applies bioinformatics to optimize bioprocesses, increasing diagnostic efficiency, and provide contract research services, focusing on next generation genomics. | Location Raleigh |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Astellas Gene Therapies | Activity: Production and Manufacturing | Company Description Astellas Gene Therapies manufactures AAV gene therapy products for rare diseases. | Location Sanford |
| |
Company Atsena Therapeutics Inc. | Activity: Research and Development | Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. | Location Durham |
| |
Company Attagene Inc. | Activity: Contract Research and Testing | Company Description Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals, environmental chemicals and natural products on over 100 transcription factors and 48 nuclear receptors. | Location Morrisville |
| |
Company Baebies Inc. | Activity: Production and Manufacturing | Company Description Baebies is a medical device company that develops and commercializes products to enable early disease detection and comprehensive diagnosis for children and adults. | Location Durham |
| |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. | Location Morrisville |
| |
Company Beam Therapeutics | Activity: Production and Manufacturing | Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. | Location Durham |
| |
Company Bedrock Therapeutics Inc. | Activity: Research and Development | Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. | Location Raleigh |
| |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Biofidelity Inc. | Activity: Research and Development | Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. | Location Morrisville |
| |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park |
| |
Company BioGenomics LLC | Activity: Contract Research and Testing | Company Description BioGenomics provides pharmacogenomic testing to inform prevention, diagnosis and treatment of various diseases. | Location Knightdale |
| |
Company Biorg Inc. | Activity: Research and Development | Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. | Location Winston-Salem |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh |
| |
Company Carolina BioOncology Institute | Activity: Support and Related | Company Description CBI runs a phase I immunotherapy and personalized cancer clinical trial program, and serves as an incubator for BioCytics, its research and application program. | Location Huntersville |
| |
Company CARsgen Therapeutics | Activity: Production and Manufacturing | Company Description CARsgen Therapeutics develops innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. | Location Durham |
| |
Company CasTag Biosciences Inc. | Activity: Production and Manufacturing | Company Description CasTag Biosciences provides custom AAV kits. It uses CRISPR knock-in technology to produce genome-wide arrayed libraries with a variety of donors for endogenous protein analysis in cells and tissue. | Location Durham |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |